COMPARISON OF METFORMIN WITH VITAMIN D SUPPLEMENTATION AND METFORMIN ALONE INTERMS OF REDUCTION IN LEVEL OF HBA1C IN PATIENTS DIAGNOSED WITH DIABETES MELLITUS TYPE II
DOI:
https://doi.org/10.71000/anbwwk77Keywords:
Diabetes Mellitus, Type 2, Glycated Hemoglobin A, Metformin, Randomized Controlled Trial, Vitamin D, Vitamin D Deficiency, Vitamin D Supplementation.Abstract
Background: Type 2 diabetes mellitus (T2DM) is a progressive metabolic disorder characterized by insulin resistance and chronic hyperglycemia. Metformin remains the cornerstone of T2DM therapy, yet emerging evidence suggests vitamin D supplementation may enhance glycemic control due to its role in insulin sensitivity and secretion.
Objective: To compare the efficacy of metformin combined with vitamin D supplementation versus metformin alone in reducing HbA1c levels in patients with T2DM.
Methods: This randomized controlled trial was conducted at the Department of Medicine, Khyber Teaching Hospital, Peshawar. A total of 140 patients with T2DM were randomly assigned to two groups: Group A received metformin (500 mg/day) plus vitamin D (200,000 IU/month), and Group B received metformin alone, over a period of three months. Demographic data, baseline HbA1c levels, and post-treatment values were recorded. Data were analyzed using SPSS v25, with a significance level set at p<0.05.
Results: Both groups were demographically comparable. The mean baseline HbA1c levels were 63.5 mmol/mol in Group A and 63.2 mmol/mol in Group B. After three months, Group A showed a greater mean reduction in HbA1c (10.1 mmol/mol) compared to Group B (7.2 mmol/mol), indicating statistically significant improvement in glycemic control with the addition of vitamin D. No serious adverse events were reported.
Conclusion: Vitamin D supplementation as an adjunct to metformin therapy demonstrated superior reduction in HbA1c levels among T2DM patients. These findings support the integration of vitamin D in diabetes management, particularly in regions with high prevalence of deficiency.
References
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):627-35.
Jha SC, Kumar H, Faisal SY. Correlation between Vitamin D and HbA1c in Type 2 diabetic patients. Acad J Med. 2020;3(1):4-10.
Cojic M, Kocic R, Klisic A, Kocic G. The effects of vitamin D supplementation on metabolic and oxidative stress markers in patients with type 2 diabetes: A 6-month follow up randomized controlled study. Front Endocrinol. 2021;12(7):41-6.
Szymczak-Pajor I, Drzewoski J, Śliwińska A. The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders. Int J Mol Sci. 2020;21(18):664-72.
Contreras-Bolívar V, García-Fontana B, García-Fontana C, Muñoz-Torres M. Mechanisms involved in the relationship between vitamin D and insulin resistance: impact on clinical practice. Nutrients. 2021;13(10):349-55.
Derosa G, D'Angelo A, Martinotti C, Valentino MC, Di Matteo S, Bruno G, et al. Vitamin D3 supplementation improves glycemic control in type 2 diabetic patients: Results from an Italian clinical trial. International journal for vitamin and nutrition research Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung Journal international de vitaminologie et de nutrition. 2020:1-10.
Wahba NS, Abdel-Ghany RH, Ghareib SA, Abdel-Aal M, Alsemeh AE, Sabry D. Vitamin D3 potentiates the nephroprotective effects of vildagliptin-metformin combination in a rat model of metabolic syndrome. Fundam Clin Pharmacol. 2022;36(2):306-23.
Aludwan M, Kobyliak N, Abenavoli L, Kyriienko D, Fagoonee S, Pellicano R, et al. Vitamin D3 deficiency is associated with more severe insulin resistance and metformin use in patients with type 2 diabetes. Minerva Endocrinol. 2020;45(3):172-80.
Tang L, Zhang D, Zhang Y, Peng Y, Li M, Song H, et al. Vitamin D3 alleviates lung fibrosis of type 2 diabetic rats via SIRT3 mediated suppression of pyroptosis. Apoptosis. 2023;28(11-12):1618-27.
Khan IA, Chandra S, Kanojia ML. Vitamin D as add on Therapy to Metformin and Teneligliptin in patients with type 2 Diabetes Mellitus. Research Journal of Pharmacy and Technology. 2023.
Odetayo AF, Abdulrahim HA, Fabiyi OT, Adewole TA, Ajiboye BE, Omeiza AN, et al. Synergistic Effects of Vitamin D and Exercise on Diabetes-induced Gonadotoxicity in Male Wistar Rats: Role of Xanthine Oxidase/Uric Acid and Nrf2/NfkB Signaling. Cell Biochem Biophys. 2024;82(3):2065-77.
Tracer H, West R. Screening for Vitamin D Deficiency in Adults. Am Fam Physician. 2021;104(5):515-6.
Cojic M, Kocić R, Klisić A, Cvejanov-Kezunović L, Kavaric N, Kocic G. A novel mechanism of vitamin D anti-inflammatory/antioxidative potential in type 2 diabetic patients on metformin therapy. Archives of Medical Science : AMS. 2020;16:1004-12.
Abdulrahim HA, Odetayo AF, Owootori EA, Bulus JD, Jimoh FB, Gabriel EO, et al. Metformin and vitamin D combination therapy ameliorates type 2 diabetes mellitus-induced renal injury in male Wistar rats. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(3):3133-46.
Krysiak R, Kowalcze K, Okopień B. Impaired metabolic effects of metformin in men with early-onset androgenic alopecia. Pharmacol Rep. 2022;74(1):216-28.
Lievykh A, Zhyliuk V, Ushakova G, Tkachenko V, Kovalchuk Y, Dovban O, et al. Impact of Vitamin D3 on Carbonyl-Oxidative Stress and Matrix Metalloproteinases after Acute Intracerebral Hemorrhage in Rats with Type 2 Diabetes Mellitus. Endocr Metab Immune Disord Drug Targets. 2023;23(10):1326-39.
Cojic M, Kocic R, Klisic A, Kocic G. The Effects of Vitamin D Supplementation on Metabolic and Oxidative Stress Markers in Patients With Type 2 Diabetes: A 6-Month Follow Up Randomized Controlled Study. Front Endocrinol (Lausanne). 2021;12:610893.
Cojic MM, Klisic A, Kocic R, Veljkovic A, Kocic G. Data-Driven Cluster Analysis of Oxidative Stress Indexes in relation to Vitamin D Level, Age, and Metabolic Control in Patients with Type 2 Diabetes on Metformin Therapy. Oxid Med Cell Longev. 2021;2021:7942716.
Tyagi S, Mani S. Combined Administration of Metformin and Vitamin D: A Futuristic Approach for Management of Hyperglycemia. Cardiovascular & hematological agents in medicinal chemistry. 2023.
Odetayo A, Abdulrahim H, Yusuf AM, Aromokhame WO, Olaitan AM, Ugoji MC, et al. Combination Therapy with Vitamin D and Metformin: A Potential Approach to Mitigate Testicular Dysfunction in Type 2 Diabetes Mellitus. Reproductive sciences. 2024.
Yan X, Li X, Liu B, Huang J, Xiang Y, Hu Y, et al. Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial. Signal Transduct Target Ther. 2023;8(1):158.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Zahid Ullah, Inam Ullah Khan, Sohrab Khan, Saif Ullah, Muhammad Aman Khan, Mian Imad Ahmed (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
